Alex Mandel

Alex Mandel is an experienced chemist specializing in synthetic chemistry for targeted radiopharmaceuticals. Currently serving as the Director of Chemistry at Abdera Therapeutics since January 2024, Mandel previously held the role of Senior Scientist at the same organization and led various synthetic chemistry programs. Prior experience includes key positions at adMare BioInnovations, where leadership in new targeted alpha therapy and radioconjugate research took place, and at The Centre for Drug Research & Development, contributing to novel technologies in antibody-drug conjugates and radioimmunotherapy. Academic credentials include a PhD in Organic Chemistry from UC San Diego and a BS in Chemistry from Harvey Mudd College.